ROYAL BANK OF CANADA - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 36 filers reported holding APTEVO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,000
+50.0%
1,700
+138.1%
0.00%
Q3 2022$2,000
-33.3%
7140.0%0.00%
Q2 2022$3,000
-66.7%
714
-55.8%
0.00%
Q1 2022$9,000
-30.8%
1,6140.0%0.00%
Q4 2021$13,000
-48.0%
1,6140.0%0.00%
Q3 2021$25,000
-30.6%
1,6140.0%0.00%
Q2 2021$36,000
+5.9%
1,614
+44.9%
0.00%
Q1 2021$34,000
+30.8%
1,114
+56.0%
0.00%
Q4 2020$26,000
+420.0%
7140.0%0.00%
Q3 2020$5,000
-16.7%
714
-5.7%
0.00%
Q2 2020$6,000
+100.0%
757
-9.8%
0.00%
Q1 2020$3,0008390.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$39,477,0007.86%
RTW INVESTMENTS, LP 281,402$6,312,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 187,995$4,217,0000.09%
Anson Funds Management LP 35,587$798,0000.08%
Alyeska Investment Group, L.P. 139,172$3,122,0000.04%
Dynamic Technology Lab Private Ltd 14,022$315,0000.03%
JBF Capital, Inc. 3,907$88,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,350$344,0000.01%
Renaissance Technologies 159,923$3,587,0000.00%
QS Investors, LLC 15,650$352,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders